Kazakhstan's pharmaceutical market remains the most accessible, transparent and, from a legislative point of view, progressive in Central Asia. In terms of market size, its potential is limited by its relatively small population (15mn) and logistical challenges.
In the short term, Kazakhstan's market development is driven by a balanced policy of import substitution and integration into regional (Customs Union) and global (World Trade Organisation) systems.
Over the longer term, the country could leverage its favorable business environment and regional ties to supply neighboring states, such as Uzbekistan, Kyrgyzstan, Turkmenistan and Tajikistan, all of which have growing populations and lack domestic production capacity.
The country's government is in the middle of implementing an industrial development policy for pharmaceuticals.